Gabelli & Co Investment Advisers’s Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share VHAQ.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding VHAQ.WS
Gabelli & Co Investment Advisers's VHAQ.WS Position: Q4 2023 in Review
Gabelli & Co Investment Advisers sold out of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) in Q4 2023, closing a stake of 60,178 shares — an estimated $1.56K sold.
Gabelli & Co Investment Advisers first reported a position in VHAQ.WS in Q2 2021 and held it in 10 quarters. The position peaked at $63K in Q2 2021. 6 funds tracked by Wall St. Rank hold VHAQ.WS as of Q4 2023.
- Gabelli & Co Investment Advisers reported no remaining Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position as of Q4 2023 after selling out during the quarter.
- Gabelli & Co Investment Advisers sold 60,178 Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share shares in Q4 2023, an estimated $1.56K.
- Gabelli & Co Investment Advisers first reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in Q2 2021 and held it in 10 quarters.
- Gabelli & Co Investment Advisers's Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position peaked at $63K in Q2 2021.
- 6 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share as of Q4 2023.
Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2023, filed 13 Feb 2024.